Bartalena L, Pacchiarotti A, Palla R, Antonangeli L, Mammoli C, Monzani F, De Negri F, Panichi V, Martino E, Baschieri L
Istituto di Endocrinologia, University of Pisa, Italy.
Clin Nephrol. 1990 Jul;34(1):30-4.
Thyrotropin (TSH) secretion was evaluated in a group of patients with chronic renal failure (CRF) undergoing regular maintenance hemofiltration and in normal controls. The study group included 68 patients (39 males and 29 females, age range 39-73 years, mean: 53 years). In all patients blood was drawn at 08:30-09:00 h; in 20 patients the nocturnal (24:00-02:00 h) serum TSH peak was also evaluated; 12 patients underwent stimulation test with synthetic TSH-releasing hormone (TRH). TSH was measured by an ultrasensitive immunoradiometric assay. CRF patients showed a significant decrease in serum total and free thyroxine and triiodothyronine concentrations, which in a substantial proportion of subjects were below the lower normal limit. Serum reverse triiodothyronine and thyroxine-binding globulin values did not differ in the two groups. Despite this trend of thyroid hormones to decrease, no patient had supranormal TSH values as in primary hypothyroidism. While the mean morning TSH concentrations of CRF patients did not differ from those of controls, the mean nocturnal values were significantly reduced in CRF (1.0 +/- 0.2 vs 3.2 +/- 0.4 mU/l, p less than 0.0005) and the nocturnal serum TSH surge was not observed in 18 of the 20 patients (90%) in whom it was evaluated. The mean serum TSH peak value after TSH-releasing hormone (TRH) administration was also reduced in CRF patients, and the TSH response to TRH was blunted in 3 out of 12 patients (25%). The results of this study demonstrate a major impairment of TSH secretion in CRF, which baseline TSH measurements in the morning and the evaluation of the TSH response to TRH may not reveal.(ABSTRACT TRUNCATED AT 250 WORDS)
对一组接受定期维持性血液滤过的慢性肾衰竭(CRF)患者及正常对照组的促甲状腺激素(TSH)分泌情况进行了评估。研究组包括68例患者(39例男性和29例女性,年龄范围39 - 73岁,平均53岁)。所有患者均于08:30 - 09:00采集血液;对20例患者还评估了夜间(24:00 - 02:00)血清TSH峰值;12例患者接受了合成促甲状腺激素释放激素(TRH)刺激试验。TSH采用超灵敏免疫放射分析测定。CRF患者血清总甲状腺素、游离甲状腺素和三碘甲状腺原氨酸浓度显著降低,相当一部分患者低于正常下限。两组血清反三碘甲状腺原氨酸和甲状腺素结合球蛋白值无差异。尽管甲状腺激素有下降趋势,但无患者出现原发性甲状腺功能减退时的TSH值高于正常情况。虽然CRF患者早晨TSH平均浓度与对照组无差异,但CRF患者夜间平均TSH值显著降低(1.0±0.2 vs 3.2±0.4 mU/L,p<0.0005),在评估的20例患者中有18例(90%)未观察到夜间血清TSH高峰。CRF患者给予促甲状腺激素释放激素(TRH)后血清TSH峰值平均值也降低,12例患者中有3例(25%)对TRH的TSH反应减弱。本研究结果表明CRF患者TSH分泌存在严重受损,早晨基础TSH测量及TSH对TRH反应评估可能无法揭示这一点。(摘要截断于250字)